Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coordination of two kinesin superfamily motor proteins, KIF3A and KIF13A, is essential for pericellular matrix degradation by membrane-type 1 matrix metalloproteinase (MT1-MMP) in cancer cells. | Matrix Biol | 2022 | 35122963 | PubTator, text mining | PubMed |
| Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1. | Curr Opin Virol | 2022 | 35121335 | PubTator, text mining | PubMed |
| The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression. | Oncogene | 2022 | 35102251 | PubTator, text mining | PubMed |
| KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block. | Ther Adv Respir Dis | 2022 | 35098800 | PubTator, text mining | PubMed |
| Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. | Clin Respir J | 2022 | 35081265 | PubTator, text mining | PubMed |
| The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma. | Open Med (Wars) | 2022 | 35071774 | PubTator, text mining | PubMed |
| Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients. | Ann Oncol | 2022 | 35066105 | PubTator, text mining | PubMed |
| Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma. | Clin Transl Med | 2022 | 35061935 | PubTator, text mining | PubMed |
| CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses. | J Clin Invest | 2022 | 35061630 | PubTator, text mining | PubMed |
| Structural and functional insight into regulation of kinesin-1 by microtubule-associated protein MAP7. | Science | 2022 | 35050657 | PubTator, text mining | PubMed |
| Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometry. | Nat Commun | 2022 | 35013269 | PubTator, text mining | PubMed |
| Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | Mol Cell Proteomics | 2022 | 35007762 | PubTator, text mining | PubMed |
| Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. | JCO Precis Oncol | 2022 | 35005993 | PubTator, text mining | PubMed |
| Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer. | Cancer Sci | 2022 | 34997674 | PubTator, text mining | PubMed |
| Structural transitions in the GTP cap visualized by cryo-electron microscopy of catalytically inactive microtubules. | Proc Natl Acad Sci U S A | 2022 | 34996871 | PubTator, text mining | PubMed |
| GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease. | J Alzheimers Dis | 2022 | 34958040 | PubTator, text mining | PubMed |
| Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. | Mol Oncol | 2022 | 34875133 | PubTator, text mining | PubMed |
| Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer. | Am J Health Syst Pharm | 2022 | 34864862 | PubTator, text mining | PubMed |
| Recurrent PTPRZ1-MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases. | Cancer Sci | 2022 | 34812554 | PubTator, text mining | PubMed |
| Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review. | Intern Med | 2022 | 34803090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=34